Sirolimus-Eluting Electrospun-Produced Matrices as Coatings for Vascular Stents: Dependence of Drug Release on Matrix Structure and Composition of the External Environment
Although a number of drug-eluting coatings for vascular stents (VSs) have been developed and are in commercial use, more efficient stent coatings and drug delivery systems are needed. Sirolimus (SRL) is a clinically important drug with antiproliferative and immunosuppressive activities that is widel...
Main Authors: | Zhanna K. Nazarkina, Boris P. Chelobanov, Vera S. Chernonosova, Irina V. Romanova, Andrey A. Karpenko, Pavel P. Laktionov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Materials |
Subjects: | |
Online Access: | https://www.mdpi.com/1996-1944/13/12/2692 |
Similar Items
-
Influence of Elongation of Paclitaxel-Eluting Electrospun-Produced Stent Coating on Paclitaxel Release and Transport Through the Arterial Wall after Stenting
by: Zhanna K. Nazarkina, et al.
Published: (2021-04-01) -
Vascular Stents Coated with Electrospun Drug-Eluting Material: Functioning in Rabbit Iliac Artery
by: Konstantin A. Kuznetsov, et al.
Published: (2020-08-01) -
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01) -
Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
by: Prashanth Panduranga, et al.
Published: (2011-01-01) -
The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
by: Alberto Chisari, et al.
Published: (2016-09-01)